Lindbrook Capital, LLC Relay Therapeutics, Inc. Transaction History

Lindbrook Capital, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 31, 2024	BUY	$5.9 - $8.02 $1,793 - $2,438	304 Added 89.15%	645 $4,000
Q1 2024 Apr 25, 2024	SELL	$7.5 - $12.07 $795 - $1,279	-106 Reduced 23.71%	341 $2,000
Q4 2023 Jan 31, 2024	BUY	$6.01 - $11.48 $1,394 - $2,663	232 Added 107.91%	447 $4,000
Q3 2023 Oct 25, 2023	BUY	$8.24 - $12.97 $535 - $843	65 Added 43.33%	215 $1,000
Q2 2023 Jul 28, 2023	BUY	$9.99 - $18.27 $219 - $401	22 Added 17.19%	150 $1,000
Q1 2023 Apr 26, 2023	BUY	$15.0 - $22.76 $1,740 - $2,640	116 Added 966.67%	128 $2,000
Q4 2022 Jan 24, 2023	SELL	$14.16 - $24.02 $3,582 - $6,077	-253 Reduced 95.47%	12 $0
Q3 2022 Nov 10, 2022	BUY	$18.07 - $31.37 $2,656 - $4,611	147 Added 124.58%	265 $6,000
Q2 2022 Aug 01, 2022	BUY	$13.31 - $34.88 $212 - $558	16 Added 15.69%	118 $2,000
Q1 2022 Apr 21, 2022	BUY	$20.26 - $32.36 $2,066 - $3,300	102 New	102 $3,000

203

156M

207K

40K

Ticker RLAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 120,219,000
Market Cap $577M
Description
Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Lindbrook Capital, LLC with notifications on news.